April 20, 1990 |
UC Irvine scientists have identified and cloned a substance that appears to block the human body's natural weapons against cancer tumors. The protein appears to prevent both white blood cells and a compound produced by the body's immune system from attacking cancer cells directly, a UCI research team reported today in the journal Cell. The receptor protein may be blocking the beneficial effects of a new cancer therapy now being tested, research team leader Gale Granger said.
January 12, 1989 |
"To good genes," toasted John Wasmuth, Ph.D., as he lifted a glass of wine at dinner Tuesday in UC Irvine's University Club. Unbeknown to Wasmuth, a genetic researcher and professor of biochemistry, the highlight of the evening would be when he stepped up to the podium to accept the Research Associates' annual achievement award--a Baccarat vase and $5,500 grant to further his work in molecular genetics. At the time of his toast, the good doctor was still in the dark.
CALIFORNIA | LOCAL
May 24, 1994 |
A new blood test for ovarian cancer developed at UC Irvine has become the focus of a national study to determine if eventually it could speed detection of the disease, which often kills its victims by growing undiscovered. With the approval of the National Cancer Institute, 140 women with ovarian cancer will be followed from their original diagnosis through two years of treatment, including surgery and chemotherapy, to see if the test can accurately detect changing levels of malignancy. Dr.
May 7, 1986 |
The exclusive Center Club provided just the right atmosphere Saturday night for "An Evening of Elegance," a black-tie fund-raiser that drew 135 supporters of the Newport Beach-based National Society for Immunology. The event, organized by the Orange County Council for Immunology, raised nearly $20,000 for UC Irvine research on allergies and such diseases as AIDS, multiple sclerosis and lupus.
December 11, 1998 |
Newly released documents show that a cancer-stricken Florida girl was given experimental treatments in a UC Irvine program after intervention from higher officials, and that two cancer doctors conducted "clandestine" research to help her.
CALIFORNIA | LOCAL
July 10, 1999 |
UC Irvine improperly charged dying cancer patients and Medicare more than $55,000 for experimental drug treatments in 1995 and 1996, payments tied to a problem-plagued research project that was later shut down, university officials acknowledged Friday. The billing problems were uncovered in a UCI audit launched shortly after federal health officials began investigating reports of unauthorized research by the cancer laboratory's doctors.